Selenium Deficiency a Factor in Endemic Goiter Persistence in Sub-Saharan Africa

被引:13
作者
Kishosha, P. A. [1 ,2 ]
Galukande, M. [1 ]
Gakwaya, A. M. [3 ]
机构
[1] Makerere Univ, Dept Surg, Coll Hlth Sci, Kampala, Uganda
[2] Mwanza Zonal Mil Hosp, Mwanza, Tanzania
[3] Mulago Hosp, Dept Surg, Kampala, Uganda
关键词
IODINE; SUPPLEMENTATION;
D O I
10.1007/s00268-011-1096-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Goiter is still common in Uganda, despite the present iodized salt coverage of at least 95%. Where there is endemic goiter after adequate iodine supplementation, selenium deficiency could be a factor for the continued occurrence of goiter. The objectives of the present study, therefore, were to determine the serum selenium levels among goitrous patients and nongoitrous controls and to determine the association between goiter and selenium levels among these patients. Methods The investigation was designed as a case control study in which 92 subjects were enrolled, 46 cases and 46 controls of similar age and sex distribution. Subjects were interviewed and examined. Blood samples were taken and selenium concentrations were determined by electrothermal atomic absorption spectrometry. Results The overall mean serum selenium levels were 77.25 mu g/l (SD 16.78) for the goiter patients and 95.50 mu g/l (24.47) for the nongoiter controls. The difference between goitrous and nongoitrous populations was statistically significant (p = 0.0001). Selenium levels above 102.8 mu g/l had a statistically significant protective effect against goiter with adjusted odds ratio 0.3 (0.13-0.69); p = 0.005. Other factors, such as age, main food constituent, and use of iodized salt, had no association with goiter. Conclusions There were significant differences between selenium levels among goitrous patients and nongoitrous controls. High selenium levels seem to have a protective effect against goiter. Selenium supplementation as a preventive strategy is worth further exploration
引用
收藏
页码:1540 / 1545
页数:6
相关论文
共 36 条
[1]  
[Anonymous], 2005, MULAGO HOSP PATIENT
[2]  
Arnaud Josiane, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P81, DOI 10.2114/jpa.20.81
[3]   Selenium and endocrine systems [J].
Beckett, GJ ;
Arthur, JR .
JOURNAL OF ENDOCRINOLOGY, 2005, 184 (03) :455-465
[4]   IDENTIFICATION OF TYPE-I IODOTHYRONINE 5'-DEIODINASE AS A SELENOENZYME [J].
BEHNE, D ;
KYRIAKOPOULOS, A ;
MEINHOLD, H ;
KOHRLE, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (03) :1143-1149
[5]  
Bimenya Gabriel S, 2002, Afr Health Sci, V2, P63
[6]   EFFECTS OF SELENIUM DEFICIENCY ON THYROID NECROSIS, FIBROSIS AND PROLIFERATION - A POSSIBLE ROLE IN MYXEDEMATOUS CRETINISM [J].
CONTEMPRE, B ;
DUMONT, JE ;
DENEF, JF ;
MANY, MC .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (01) :99-109
[7]   Low serum selenium concentration as a possible factor for persistent goiter in Iranian school children [J].
Dabbaghmanesh, Mohammad Hossein ;
Sadegholvaad, Abdolsamad ;
Ejtehadi, Fardad ;
Omrani, Gholamhossein .
BIOFACTORS, 2007, 29 (2-3) :77-82
[8]   Association of selenium with thyroid volume and echostructure in 35-to 60-year-old French adults [J].
Derumeaux, H ;
Valeix, P ;
Castetbon, K ;
Bensimon, M ;
Boutron-Ruault, MC ;
Arnaud, J ;
Hercberg, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (03) :309-315
[9]  
Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630
[10]  
FAIRWEATHERTAIT SJ, 1997, EUROPEAN J CLIN NUTR, V51, P520